Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers.
作者信息
Criscitiello Carmen, Santangelo Michele, Loupakis Fotios
机构信息
Division of Early Drug Development, European Institute of Oncology, Milano, Italy.
Department of Advanced Biomedical Science, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.
出版信息
Biomed Res Int. 2018 Mar 20;2018:5184075. doi: 10.1155/2018/5184075. eCollection 2018.
Abstract
摘要
相似文献
1
Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers.
Biomed Res Int. 2018 Mar 20;2018:5184075. doi: 10.1155/2018/5184075. eCollection 2018.
2
The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review.
Semin Cancer Biol. 2018 Oct;52(Pt 2):12-15. doi: 10.1016/j.semcancer.2017.09.006. Epub 2017 Sep 22.
3
Biomarker search illuminates cancer immune biology.
Nat Rev Drug Discov. 2016 Jun 30;15(7):443-5. doi: 10.1038/nrd.2016.131.
4
Cancer Immunology and Cancer Immunodiagnosis 2016.
J Immunol Res. 2017;2017:9127382. doi: 10.1155/2017/9127382. Epub 2017 Jan 10.
5
Cancer immunotherapy in 2017: The breakthrough of the microbiota.
Nat Rev Immunol. 2018 Jan 30;18(2):87-88. doi: 10.1038/nri.2018.4.
6
CANCER IMMUNOLOGY. The "cancer immunogram".
Science. 2016 May 6;352(6286):658-60. doi: 10.1126/science.aaf2834.
7
[Which future for B lymphocytes infiltrating solid tumors: prognostic biomarker and/or therapeutic target?].
Med Sci (Paris). 2018 Jan;34(1):72-78. doi: 10.1051/medsci/20183401016. Epub 2018 Jan 31.
8
Liquid Biopsies and Cancer Immunotherapy.
Cancer J. 2018 Mar/Apr;24(2):78-83. doi: 10.1097/PPO.0000000000000307.
9
Immunotherapy of human cancer: lessons from mice.
Nat Immunol. 2000 Nov;1(5):363-6. doi: 10.1038/808795.
10
Towards In Silico Prediction of the Immune-Checkpoint Blockade Response.
Trends Pharmacol Sci. 2017 Dec;38(12):1041-1051. doi: 10.1016/j.tips.2017.10.002. Epub 2017 Oct 28.
引用本文的文献
1
Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives.
Diagnostics (Basel). 2020 Mar 7;10(3):146. doi: 10.3390/diagnostics10030146.
本文引用的文献
1
Tissue-Agnostic Drug Development.
Am Soc Clin Oncol Educ Book. 2017;37:222-230. doi: 10.1200/EDBK_173855.
Zotero 插件